Literature DB >> 35140356

Blocking breast cancer metastasis.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2022        PMID: 35140356     DOI: 10.1038/d41573-022-00026-0

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.

Authors:  Meiling Zhang; Zongzhi Z Liu; Keisuke Aoshima; Wesley L Cai; Hongyin Sun; Tianrui Xu; Yangyi Zhang; Yongyan An; Jocelyn F Chen; Lok Hei Chan; Asako Aoshima; Sabine M Lang; Zhenwei Tang; Xuanlin Che; Yao Li; Sara J Rutter; Veerle Bossuyt; Xiang Chen; Jon S Morrow; Lajos Pusztai; David L Rimm; Mingzhu Yin; Qin Yan
Journal:  Sci Transl Med       Date:  2022-02-02       Impact factor: 19.319

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.